Ginkgo Bioworks Inc.
DNA | NYSE
$7.98
+$0.10 (+1.27%)
At close: Sep 21, 2026, 4:00 PM ET
$7.90
-$0.08 (-1.00%)
Pre-market:
Sep 22, 2026, 5:48 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -53.24M | -76.06M | -80.75M | -80.76M | -60.3M | -90.96M | -107.53M | -56.4M | -217.18M | -165.91M | -211.69M | -302.89M | -173.32M | -204.97M | -175.47M | -670.13M | -668.83M | -590.51M | -1.6B | -101.88M | -53.94M | -73.57M |
Depreciation & Amortization | 12.32M | 12.8M | 13.66M | 14.17M | 15.79M | 15.37M | 15.65M | 17.17M | 17.33M | 12.87M | 12.84M | 21.06M | 25.94M | 27M | 17.54M | 8.92M | 9.61M | 9.49M | 8M | 8.28M | 7.17M | 5.63M |
Stock-Based Compensation | 7.6M | 15.85M | 21.03M | 17.84M | 22.25M | 20.43M | 20.56M | n/a | 37.15M | 40.78M | n/a | 52.57M | n/a | n/a | 118.45M | n/a | n/a | n/a | n/a | 127K | n/a | n/a |
Other Working Capital | 2.34M | -2.34M | -1.79M | 13.02M | -15.45M | -13.29M | -35.07M | -51.08M | 219K | -3.79M | 9.52M | 219K | -21.81M | -9.52M | -42.42M | -4.79M | -34.3M | 3.86M | -7.55M | 43.12M | 6.56M | 12.78M |
Other Non-Cash Items | -23.02M | 15.15M | 23.33M | 3.36M | 4.72M | 15.2M | 26.71M | 33.77M | 72.44M | 22.69M | 99.77M | 157.53M | 85.72M | 85.9M | -57.13M | 598.67M | 612.89M | 571.27M | 1.52B | 68.07M | 9.38M | 16.74M |
Deferred Income Tax | n/a | n/a | -1.36M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -801K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 9.99M | -14.18M | -23.59M | 13.78M | -22.71M | -11.57M | 2.18M | -98.04M | 5.88M | 312K | 42.06M | -1.83M | -11.88M | 1.49M | -7.92M | 34.07M | -52.97M | -10.15M | -92.34M | 20.17M | 2.49M | 3.07M |
Operating Cash Flow | -46.36M | -46.43M | -47.68M | -31.61M | -40.25M | -51.52M | -42.44M | -103.5M | -84.39M | -89.26M | -57.83M | -73.55M | -73.53M | -90.59M | -104.53M | -28.47M | -99.3M | -19.9M | -165.54M | -5.24M | -34.91M | -48.13M |
Capital Expenditures | -2.62M | -1.93M | -15.33M | n/a | -38K | -7.62M | -13.71M | -15.09M | -27.03M | -6.71M | -3.45M | -4.38M | -13.53M | -19.44M | -25.65M | -13.47M | -9.57M | -3.58M | -5.11M | -5.44M | -24.03M | -21.94M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | 57K | 400K | 191K | -5.4M | -41.55M | n/a | 2.31M | 617K | 74.73M | -57.05M | 1.44M | n/a | 9.28M | -20.17M | n/a | -1.21M |
Purchase of Investments | -44.28M | -83.16M | -16.79M | -81.71M | -128.95M | -191.18M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6.5M | -6.5M | -3.69M | -5M | n/a | n/a | n/a |
Sales Maturities Of Investments | 57.99M | 108.18M | 185.38M | 8.64M | 64.96M | n/a | 568K | 3.95M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | 48K | -58.17M | 249K | 142K | 120K | n/a | 538K | n/a | n/a | -1.68M | 1M | n/a | -590K | -19.34M | 17.54M | -30K | -28.71M | 5M | -4.9M | 103K | 99K |
Investing Cash Flow | 11.09M | 23.13M | 95.1M | -72.82M | -63.89M | -198.68M | -13.09M | -10.2M | -26.84M | -12.11M | -46.67M | -3.38M | -11.22M | -19.41M | 29.74M | -46.49M | -14.66M | -35.99M | 4.16M | -30.51M | -23.93M | -23.05M |
Debt Repayment | n/a | -19K | -25K | -24K | -98K | -207K | -203K | -200K | -200K | -294K | -318K | -329K | -326K | -322K | -325K | -192K | -434K | -286K | -359K | -316K | -163K | -285K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -981K | n/a | n/a | n/a | n/a | -892.25M | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 19K | n/a | n/a | n/a | n/a | n/a | 4K | -265K | -40K | -621K | 173K | 14K | -1.62M | n/a | 99.07M | -12K | -521K | -981K | -9.46M | 2.44B | n/a | n/a |
Financial Cash Flow | 19K | -19K | 8.14M | 9.94M | -98K | -207K | -203K | -465K | -226K | -845K | -632K | -315K | -1.38M | -888K | 97.76M | -280K | -954K | -1.19M | -10.98M | 1.55B | -2.12M | -433K |
Net Cash Flow | -35.12M | -23.34M | 54.36M | -94.39M | -105.85M | -250.34M | -55.8M | -113.65M | -111.05M | -105.09M | -103.73M | -77.44M | -85.97M | -109.78M | 24.07M | -72.19M | -113.78M | -54.84M | -189.05M | 1.51B | -1.88M | -378.88M |
Free Cash Flow | -48.98M | -48.37M | -63M | -31.61M | -40.29M | -59.14M | -56.15M | -118.59M | -111.42M | -95.97M | -61.28M | -77.93M | -87.07M | -110.03M | -130.18M | -41.95M | -108.87M | -23.48M | -170.66M | -10.67M | -58.95M | -70.07M |
Adj. Free Cash Flow | -56.57M | -64.22M | -84.03M | -49.45M | -62.54M | -79.57M | -76.71M | -118.59M | -148.57M | -136.75M | -61.28M | -130.51M | -87.07M | -110.03M | -248.62M | -41.95M | -108.87M | -23.48M | -170.66M | -10.8M | -58.95M | -70.07M |
Maintenance CapEx | -2.62M | -1.93M | -15.33M | n/a | -38K | n/a | -455.23K | n/a | -27.03M | -6.71M | -3.45M | -4.38M | -13.53M | -19.44M | -25.65M | -13.47M | n/a | n/a | n/a | n/a | n/a | -4.88M |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | -7.62M | -13.25M | -15.09M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -9.57M | -3.58M | -5.11M | -5.44M | -24.03M | -17.06M |
Owner Earnings | -48.98M | -48.37M | -63M | -31.61M | -40.29M | -51.52M | -42.89M | -103.5M | -111.42M | -95.97M | -61.28M | -77.93M | -87.07M | -110.03M | -130.18M | -41.95M | -99.3M | -19.9M | -165.54M | -5.24M | -34.91M | -53.01M |
Add to Watchlist
Select watchlists to add or remove DNA